NI
ALNY icon

Numeric Investors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Numeric Investors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-11,400
Closed -$633K – 1045
2016
Q2 		$633K Buy
+11,400
New +$718K 0.01% 689
2015
Q3 		– Sell
-2,600
Closed -$312K – 971
2015
Q2 		$312K Buy
+2,600
New +$311K ﹤0.01% 752
2015
Q1 		– Sell
-10,700
Closed -$1.04M – 877
2014
Q4 		$1.04M Buy
+10,700
New +$991K 0.01% 448

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Numeric Investors's ALNY Position: Q3 2016 in Review

Numeric Investors sold out of Alnylam Pharmaceuticals (ALNY) in Q3 2016, closing a stake of 11,400 shares — an estimated $633K sold.

Numeric Investors first reported a position in ALNY in Q4 2014 and held it in 3 quarters. The position peaked at $1.04M in Q4 2014. 260 funds tracked by Wall St. Rank hold ALNY as of Q3 2016.

  • Numeric Investors reported no remaining Alnylam Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • Numeric Investors sold 11,400 Alnylam Pharmaceuticals shares in Q3 2016, an estimated $633K.
  • Numeric Investors first reported a position in Alnylam Pharmaceuticals in Q4 2014 and held it in 3 quarters.
  • Numeric Investors's Alnylam Pharmaceuticals position peaked at $1.04M in Q4 2014.
  • 260 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2016.

Based on Numeric Investors's 13F filing for Q3 2016, filed 14 Nov 2016.